Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts Details-
Title Grant Type Focus Area Country Application Due Date Real World Evidence on the Impact of Early and Appropriate Use of Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology Brazil, Chile, India, Italy, South Africa, Spain, United Kingdom Guideline Concordant Care and New Data for Patients with MIBC through la/mUCEducation Oncology USA Clinical Research Studies of Atirmociclib in HR+/HER2- and/or HER2+ Breast CancerRelease Date:Research Oncology Australia, Brazil, Canada, China, France, Germany, Italy, Japan, Korea, Mexico, Spain, Taiwan, USA, United Kingdom Quality Improvement Interventions to Enhance the Care of Patients Infected by MBL-CRE or S. maltophiliaRelease Date:Quality Improvement Inflammation & Immunology Australia, Chile, India, Italy, Spain, United Kingdom Advancing Real-World Evidence in Idiopathic Inflammatory Myopathies Through a German Disease RegistryRelease Date:Research Inflammation & Immunology Germany Real-World Evidence on Clinical Outcomes with ATM-AVI in Adult Patients with Stenotrophomonas maltophilia InfectionsRelease Date:Research Inflammation & Immunology China Real-World Evidence on Clinical Outcomes with Aztreonam-Avibactam (ATM-AVI) in Adult Patients with Limited Treatment OptionsRelease Date:Research Inflammation & Immunology China Tissue Penetration and Correlation with Clinical Outcomes of ATM-AVI in Adult Patients with Limited Treatment OptionsRelease Date:Research Inflammation & Immunology China Advancing Multidisciplinary Care in HemophiliaRelease Date:Quality Improvement Rare Disease China BCMA BsAb Educational Initiatives in 2L+ Relapsed/Refractory Multiple MyelomaRelease Date:Education Oncology USA -
Title Grant Type Focus Area Country Application Due Date Pharmacist Education in Biosimilars (Western Europe, Canada, Japan)Release Date:Education Oncology All Biosimilars in Hematologic Malignancies & Supportive CareRelease Date:Education Oncology All The Burden and Origins of Co-Infections in COVID-19 Pneumonia (Europe)Release Date:Education Hospital All Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Atopic DermatitisRelease Date:Education Inflammation & Immunology All Needs Assessment – Early Therapy Management with CDK 4/6 Inhibitors in Metastatic Breast CancerRelease Date:Education Oncology USA Advances in Atopic Dermatitis for Advanced PractitionersRelease Date:Education Inflammation & Immunology USA 2020 RD US- Next Generation PET Imaging for ATTR-CMResearch Rare Disease USA Cardiac Transthyretin Amyloid (ATTR) Fellowship Competitive Grant ProgramRelease Date:Partner: International Society of AmyloidosisFellowship Rare Disease All Management of Moderate-to-Severe Atopic Dermatitis for Dermatologists and AllergistsRelease Date:Education Inflammation & Immunology USA Pfizer and Mayo Clinic/Global Bridges–Providing Access to Learning Resources for Tobacco Dependence TreatmentRelease Date:Partner: Mayo Clinic/Global BridgesEducation Internal Medicine China, Malaysia, Taiwan, Thailand 4th Quality Improvement initiatives optimizing AF and VTE management in CanadaQuality Improvement Internal Medicine Canada 2021 Rheumatology Competitive Grant ProgramRelease Date:Research Inflammation & Immunology USA